Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials

In the treatment of pulmonary diseases the inhalation of aerosols plays a key role - it is the preferred route of drug delivery in asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. But, in contrast to oral and intravenous administration drug delivery to the lungs is controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, A, Stegemann, J, Scheuch, G, Siekmeier, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521343/
https://www.ncbi.nlm.nih.gov/pubmed/20156730
http://dx.doi.org/10.1186/2047-783X-14-S4-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521343/
https://www.ncbi.nlm.nih.gov/pubmed/20156730
http://dx.doi.org/10.1186/2047-783X-14-S4-71

Ejemplares similares